|
nasopharyngeal carcinoma |
59 |
|
epstein-barr virus |
26 |
|
humans |
25 |
|
dna methylation |
21 |
|
female |
20 |
|
promoter hypermethylation |
18 |
|
genes, tumor suppressor |
17 |
|
nasopharyngeal carcinoma (npc) |
17 |
|
tumor suppressor |
16 |
|
whole-exome sequencing |
16 |
|
male |
15 |
|
medical sciences |
15 |
|
prognostic marker |
15 |
|
tumor suppressor gene |
15 |
|
animals |
14 |
|
metastasis |
14 |
|
oncology |
14 |
|
aged |
13 |
|
cancer susceptibility genes |
13 |
|
early-age onset |
13 |
|
ebv |
13 |
|
emt |
13 |
|
methylation |
13 |
|
middle aged |
13 |
|
mst1r |
13 |
|
nasopharyngeal neoplasms - genetics - metabolism - pathology |
13 |
|
npc |
13 |
|
tumor suppression |
13 |
|
adult |
12 |
|
apobec-mediated signature |
12 |
|
base sequence |
12 |
|
escc |
12 |
|
esophageal squamous cell carcinoma |
12 |
|
loss of heterozygosity |
12 |
|
mice |
12 |
|
mice, nude |
12 |
|
microcell-mediated chromosome transfer |
12 |
|
nf-κb signaling |
12 |
|
somatic mutation landscape |
12 |
|
tissue microarray |
12 |
|
tumor suppressor proteins - genetics - metabolism |
12 |
|
carcinoma, squamous cell - genetics - metabolism - pathology |
11 |
|
chromosomes, human, pair 14 - genetics |
11 |
|
esophageal neoplasms - genetics - metabolism - pathology |
11 |
|
esophageal squamous cell carcinoma (escc) |
11 |
|
gene expression profiling |
11 |
|
liquid biopsy |
11 |
|
nidogen-2 (nid2) |
11 |
|
prognosis |
11 |
|
signal transduction |
11 |
|
tumor microenvironment |
11 |
|
adam proteins - genetics |
10 |
|
adamts9 |
10 |
|
angiogenesis |
10 |
|
antiangiogenesis |
10 |
|
case-control study |
10 |
|
cell cycle |
10 |
|
cell line, tumor |
10 |
|
chromosomes, human, pair 3 |
10 |
|
enzyme activation |
10 |
|
epidemiology |
10 |
|
extracellular matrix protein |
10 |
|
gene expression regulation, neoplastic |
10 |
|
microcell hybrid |
10 |
|
reverse transcriptase polymerase chain reaction |
10 |
|
thy1 |
10 |
|
transfection |
10 |
|
25-hydroxyvitamin d |
9 |
|
adam proteins - biosynthesis - genetics - metabolism |
9 |
|
cell cycle arrest |
9 |
|
chromatin accessibility |
9 |
|
chromosome 6p |
9 |
|
chromosomes, human, pair 11 |
9 |
|
dietary fiber |
9 |
|
dual specificity phosphatase 6 - genetics - metabolism |
9 |
|
dual-specificity phosphatase 6 (dusp6) |
9 |
|
endothelial cells - cytology |
9 |
|
epithelial-mesenchymal transition |
9 |
|
esophageal neoplasms - blood supply - enzymology - genetics |
9 |
|
fresh vegetable and fruit |
9 |
|
genetic epidemiology |
9 |
|
genetic predisposition to disease |
9 |
|
genetic susceptibility |
9 |
|
genetic variant |
9 |
|
hong kong |
9 |
|
host-virus interaction |
9 |
|
illumina humanmethylation450 |
9 |
|
leucocyte telomere length |
9 |
|
life-course |
9 |
|
methylome |
9 |
|
mice, inbred balb c |
9 |
|
milk |
9 |
|
mipol1 |
9 |
|
multiple imputation |
9 |
|
nasopharyngeal neoplasms - blood supply - enzymology - genetics |
9 |
|
nasopharyngeal neoplasms - genetics - pathology |
9 |
|
npc risk |
9 |
|
preserved food |
9 |
|
soybean product |
9 |
|
survival |
9 |
|
telomere biology |
9 |
|
tumor stem cell assay |
9 |
|
ultraviolet radiation |
9 |
|
vitamin d |
9 |
|
vitamin d deficiency |
9 |
|
whole-genome bisulfite sequencing |
9 |
|
xenograft |
9 |
|
adaptor proteins, signal transducing - physiology |
8 |
|
alleles |
8 |
|
apoptosis |
8 |
|
biomarker |
8 |
|
carcinoma - genetics - pathology |
8 |
|
cell line, transformed |
8 |
|
cell movement |
8 |
|
cell transformation, neoplastic - genetics |
8 |
|
chromosome mapping |
8 |
|
cigarette smoking |
8 |
|
circulating neoplastic cell |
8 |
|
circulating tumor cells |
8 |
|
circulating tumor dna |
8 |
|
cytokines - genetics - physiology |
8 |
|
dose-response relation |
8 |
|
genes, tumor suppressor - physiology |
8 |
|
immortalization |
8 |
|
in situ hybridization, fluorescence |
8 |
|
longitudinal real-time monitoring |
8 |
|
microsatellite repeats - genetics |
8 |
|
nasopharyngeal neoplasms - genetics |
8 |
|
neoplasm staging |
8 |
|
neovascularization, pathologic - genetics |
8 |
|
nf-kappa b - metabolism |
8 |
|
non-invasive biomarker |
8 |
|
oligonucleotide array sequence analysis |
8 |
|
promoter regions, genetic - genetics |
8 |
|
smoking cessation |
8 |
|
survival analysis |
8 |
|
transcription regulator |
8 |
|
tumor suppressor proteins - metabolism |
8 |
|
advanced escc |
7 |
|
alpha b-crystallin (cryab) |
7 |
|
alpha-crystallin b chain - physiology |
7 |
|
anti-angiogenic |
7 |
|
azygos vein blood |
7 |
|
blm |
7 |
|
carcinoma, squamous cell - genetics |
7 |
|
carcinoma, squamous cell - genetics - pathology - secondary |
7 |
|
ccdc170 |
7 |
|
cell transformation, neoplastic |
7 |
|
cell-free dna |
7 |
|
chemoresistance |
7 |
|
chinese |
7 |
|
chromosome 11q |
7 |
|
chromosomes, human, pair 11 - genetics |
7 |
|
chromosomes, human, pair 9 - genetics |
7 |
|
circulating tumor cells (ctc) |
7 |
|
ctc clusters |
7 |
|
ctc enumeration |
7 |
|
cyclin d1 - genetics - metabolism |
7 |
|
diagnosis and prognosis |
7 |
|
dna dsb repair |
7 |
|
early prediction |
7 |
|
episome |
7 |
|
epstein-barr virus infections - complications - genetics - metabolism - virology |
7 |
|
esophageal neoplasms - genetics |
7 |
|
familial npc |
7 |
|
fibulin-2 |
7 |
|
herpesvirus 4, human - genetics - pathogenicity |
7 |
|
immunoglobulins - deficiency - genetics - physiology |
7 |
|
invasion |
7 |
|
irradiation microcell-mediated chromosome transfer |
7 |
|
lymphatic metastasis - genetics |
7 |
|
membrane proteins - deficiency - genetics - physiology |
7 |
|
microrna therapy |
7 |
|
microsatellite repeats |
7 |
|
mmp19 |
7 |
|
mutation |
7 |
|
nasopharynx - metabolism - pathology - virology |
7 |
|
nhej |
7 |
|
nucleic acid hybridization |
7 |
|
nucleosome organization |
7 |
|
oesophageal squamous cell carcinoma |
7 |
|
p38 signaling |
7 |
|
pathway associations |
7 |
|
stat5a |
7 |
|
tert |
7 |
|
vegf |
7 |
|
viral persistence |
7 |
|
whole‐exome sequencing |
7 |
|
znf750 mutation |
7 |
|
adaptor proteins, signal transducing - genetics - metabolism |
6 |
|
adherens junctions - metabolism |
6 |
|
alpha b-crystallin |
6 |
|
animal experiment |
6 |
|
animal model |
6 |
|
anti-angiogenesis |
6 |
|
antigens, thy-1 - genetics - metabolism |
6 |
|
antigens, thy-1 - physiology |
6 |
|
antiinvasive |
6 |
|
apoptosis - genetics |
6 |
|
cadherins - metabolism |
6 |
|
carcinoma - genetics |
6 |
|
carcinoma - genetics - secondary |
6 |
|
carcinoma - metabolism - pathology |
6 |
|
carcinoma, squamous cell - metabolism - mortality |
6 |
|
cell proliferation |
6 |
|
cell signaling |
6 |
|
cells, cultured |
6 |
|
china |
6 |
|
chromosome 11 |
6 |
|
chromosome 3, metastasis |
6 |
|
chromosome deletion |
6 |
|
chromosome segregation |
6 |
|
chromosomes, human, pair 13 - genetics |
6 |
|
chromosomes, human, pair 3 - genetics |
6 |
|
crip2 |
6 |
|
ctc |
6 |
|
cxcl8 |
6 |
|
cxcr2 |
6 |
|
deoxycytidine - pharmacology |
6 |
|
dna damage repair pathway |
6 |
|
dna methylation - drug effects |
6 |
|
dnmt1 |
6 |
|
e-cadherin |
6 |
|
early diagnosis |
6 |
|
enzyme-linked immunosorbent assay |
6 |
|
epithelial cells - drug effects - pathology |
6 |
|
epstein–barr virus |
6 |
|
epstein−barr virus |
6 |
|
erk1/2 |
6 |
|
esophageal cancer |
6 |
|
esophageal carcinoma |
6 |
|
esophageal neoplasms - metabolism - mortality |
6 |
|
gene expression |
6 |
|
gene expression regulation, neoplastic - drug effects |
6 |
|
gene expression regulation, neoplastic - physiology |
6 |
|
genes, cdc - physiology |
6 |
|
genome, human - genetics |
6 |
|
histone bivalent switch |
6 |
|
human leukocyte antigen |
6 |
|
hydroxamic acids - pharmacology |
6 |
|
hypermethylation |
6 |
|
inflammation |
6 |
|
latent tgf-beta binding proteins - genetics - metabolism |
6 |
|
latent transforming growth factor β binding protein 2 (ltbp-2) |
6 |
|
lim domain proteins - genetics - metabolism |
6 |
|
lmp1 |
6 |
|
loh |
6 |
|
ltbp-2 |
6 |
|
lymph nodes - pathology |
6 |
|
lymphatic metastasis |
6 |
|
metastatic growth |
6 |
|
microarray analysis |
6 |
|
mif |
6 |
|
migration |
6 |
|
mlh1 |
6 |
|
molecular sequence data |
6 |
|
molecular sequence numbers |
6 |
|
ms‐hrm |
6 |
|
mtor |
6 |
|
nasopharyngeal neoplasms - metabolism - pathology |
6 |
|
neoplasm transplantation |
6 |
|
nf-κb |
6 |
|
nidogen-2 |
6 |
|
npc genetics |
6 |
|
oligo-microarray |
6 |
|
plasmids |
6 |
|
polymerase chain reaction |
6 |
|
receptor-like protein tyrosine phosphatases, class 5 - genetics - physiology |
6 |
|
serum biomarker |
6 |
|
sulforaphane |
6 |
|
tetracycline-regulated gene expression |
6 |
|
thrombospondins - genetics - metabolism |
6 |
|
tumor cell dormancy |
6 |
|
tumor cells, cultured |
6 |
|
tumour spheres |
6 |
|
twist1 |
6 |
|
wif1 |
6 |
|
β-catenin |
6 |
|
2-methoxyestradiol |
5 |
|
3' untranslated region |
5 |
|
animal tissue |
5 |
|
antigen expression |
5 |
|
antioncogenes. |
5 |
|
blotting, western |
5 |
|
brca2 |
5 |
|
cell line |
5 |
|
chromosome 3 |
5 |
|
dna |
5 |
|
ebv‐encoded small rna |
5 |
|
egfr |
5 |
|
endoreduplication |
5 |
|
epigenetics |
5 |
|
epithelial cells - cytology |
5 |
|
esophageal cancer susceptibility gene |
5 |
|
gene expression regulation, neoplastic - genetics |
5 |
|
genetic markers |
5 |
|
genome‐wide analysis |
5 |
|
hong kong - epidemiology |
5 |
|
icg-001 |
5 |
|
la-tam |
5 |
|
loss‐of‐function mutations |
5 |
|
lymph node metastasis |
5 |
|
lymphomas-- genetic aspects. |
5 |
|
multi-omics study |
5 |
|
nasopharynx - cytology |
5 |
|
polymorphism, single nucleotide |
5 |
|
protein translation |
5 |
|
retrotransposon insertion |
5 |
|
sequencing |
5 |
|
smoking |
5 |
|
spatial analysis |
5 |
|
survival rate |
5 |
|
synthetic lethality |
5 |
|
telomerase |
5 |
|
telomerase - biosynthesis |
5 |
|
tumor segregant |
5 |
|
tumor suppressor proteins |
5 |
|
viral matrix proteins - biosynthesis |
5 |
|
antigens, cd - analysis - genetics |
4 |
|
antitumor |
4 |
|
at13387 |
4 |
|
biomarkers |
4 |
|
blotting, southern |
4 |
|
blu/zmynd10 |
4 |
|
cancer stem cell markers |
4 |
|
carcinogenicity tests |
4 |
|
carcinoma, squamous cell - chemistry - genetics - immunology - secondary |
4 |
|
cell adhesion molecules |
4 |
|
chemicals and cas registry numbers |
4 |
|
chromosome 3 transfer |
4 |
|
chromosome 3p21.3 |
4 |
|
chromosome 9 |
4 |
|
chromosomes, human, pair 14 |
4 |
|
chromosomes, human, pair 18 - genetics |
4 |
|
cohort study |
4 |
|
collagen |
4 |
|
colorectal cancer |
4 |
|
ct dna |
4 |
|
deleted in esophageal cancer 1 |
4 |
|
diagnosis |
4 |
|
differentially expressed in squamous cell carcinoma 1 |
4 |
|
dna primers |
4 |
|
dna, complementary - genetics |
4 |
|
down-regulation |
4 |
|
down-regulation - drug effects - genetics |
4 |
|
doxycycline - pharmacology - therapeutic use |
4 |
|
drug combinations |
4 |
|
ebv bart mirnas |
4 |
|
ebv serology |
4 |
|
endoglin |
4 |
|
epithelial cancer |
4 |
|
esophageal neoplasms - chemistry - genetics - pathology |
4 |
|
evi1 |
4 |
|
gene dosage |
4 |
|
gene silencing |
4 |
|
gene transfer techniques |
4 |
|
genes, p53 |
4 |
|
genetic predisposition to disease - genetics |
4 |
|
genomic instability |
4 |
|
genotype |
4 |
|
glut-1 |
4 |
|
histone deacetylase inhibitor |
4 |
|
histone modification |
4 |
|
hsp90 inhibitor |
4 |
|
hybrid cells |
4 |
|
ibd |
4 |
|
immunoglobulins - genetics |
4 |
|
individual data |
4 |
|
inherited escc |
4 |
|
innate immune response |
4 |
|
laminin |
4 |
|
lytic cycle |
4 |
|
membrane proteins - genetics |
4 |
|
mir-449a |
4 |
|
mir-96 |
4 |
|
mtorc1 |
4 |
|
nasopharyngeal neoplasms - drug therapy - genetics - pathology |
4 |
|
neoplasm invasiveness |
4 |
|
ngs analysis |
4 |
|
physiological wnt/β-catenin signaling |
4 |
|
plasma ebv dna |
4 |
|
polq |
4 |
|
polymorphism, restriction fragment length |
4 |
|
promoter regions, genetic |
4 |
|
proteoglycans |
4 |
|
receptors, cell surface - analysis - genetics |
4 |
|
references (54) view in table layout |
4 |
|
romidepsin |
4 |
|
self-renewal network |
4 |
|
senescence |
4 |
|
snp array |
4 |
|
stemness transition |
4 |
|
telomere length |
4 |
|
tp53 |
4 |
|
transmembrane serine protease |
4 |
|
transplantation, heterologous |
4 |
|
tumor suppressor genes |
4 |
|
tumor suppressor proteins - analysis - genetics |
4 |
|
tumor suppressor proteins - genetics |
4 |
|
tumorigenesis |
4 |
|
xenograft model antitumor assays - methods |
4 |
|
48 countries/regions |
3 |
|
anchorage-independent growth |
3 |
|
asian continental ancestry group |
3 |
|
bart |
3 |
|
bart microrna |
3 |
|
bcl-2/xl |
3 |
|
bioluminescence imaging |
3 |
|
cancer metastasis |
3 |
|
cancer prognosis |
3 |
|
cancer progression |
3 |
|
carcinoma - genetics - mortality |
3 |
|
carcinoma, non-small-cell lung - genetics - pathology |
3 |
|
cell signaling pathways |
3 |
|
china - epidemiology |
3 |
|
chromosome mapping - methods |
3 |
|
chromosomes, human - genetics |
3 |
|
chromosomes, human, pair 6 - genetics |
3 |
|
codon - genetics |
3 |
|
crispr/cas9 screening |
3 |
|
cylindromatosis lysine 63 deubiquitinase (cyld) |
3 |
|
dec1 |
3 |
|
deleted in oesophageal cancer 1 (dec1) |
3 |
|
dna mutational analysis |
3 |
|
dna probes |
3 |
|
dna repair gene |
3 |
|
dna, bacterial - analysis |
3 |
|
dose-response relationship, drug |
3 |
|
early detection |
3 |
|
ebv bart |
3 |
|
ecological study |
3 |
|
electrophoresis, agar gel |
3 |
|
epithelium - metabolism - pathology |
3 |
|
escherichia coli - classification - genetics - pathogenicity |
3 |
|
estradiol - analogs & derivatives - pharmacology |
3 |
|
exons |
3 |
|
family health |
3 |
|
fancd2 |
3 |
|
gene deletion |
3 |
|
genes, ras - genetics |
3 |
|
genetic markers - genetics |
3 |
|
genetic predisposition |
3 |
|
germline polymorphisms |
3 |
|
gwas |
3 |
|
hcc diagnosis |
3 |
|
hepatocellular carcinoma |
3 |
|
hla |
3 |
|
ikbb |
3 |
|
immunohistochemistry |
3 |
|
infant |
3 |
|
introns |
3 |
|
iκb kinase |
3 |
|
keratinocyte differentiation |
3 |
|
live animal imaging |
3 |
|
lncrna |
3 |
|
lung carcinoma |
3 |
|
lung neoplasms - genetics - pathology |
3 |
|
machine learning |
3 |
|
map kinase signaling system - drug effects |
3 |
|
mapk signaling pathways |
3 |
|
microrna |
3 |
|
microsatellite instability |
3 |
|
microsatellite typing |
3 |
|
milk consumption |
3 |
|
mirna signature |
3 |
|
mitochondria |
3 |
|
mitochondria - drug effects - metabolism |
3 |
|
mutations |
3 |
|
nasopharyngeal neoplasms - genetics - mortality |
3 |
|
neoplasm invasiveness - pathology |
3 |
|
neoplasms |
3 |
|
nf-kappa b |
3 |
|
nf-kb |
3 |
|
nf‐κb/akt/gsk‐3β signalling pathway |
3 |
|
noncoding rna |
3 |
|
oesophageal cancer family history |
3 |
|
orthotopic model |
3 |
|
oxidative stress |
3 |
|
oxidative stress - drug effects |
3 |
|
p53 |
3 |
|
point mutation |
3 |
|
polymorphism, genetic |
3 |
|
polymorphism, single-stranded conformational |
3 |
|
protein interactome |
3 |
|
rassf1a |
3 |
|
reference values |
3 |
|
rpa1 |
3 |
|
squamous cell carcinoma |
3 |
|
stat3/5 |
3 |
|
subcellular localisation |
3 |
|
telomere |
3 |
|
tissue array analysis |
3 |
|
tubulin modulators - pharmacology |
3 |
|
tumor markers, biological - genetics - metabolism |
3 |
|
ubiquitination |
3 |
|
whole-exome sequencing (wes) |
3 |
|
zinc finger protein 750 |
3 |
|
3p21.3 |
2 |
|
adamts18 |
2 |
|
adenocarcinoma |
2 |
|
adenocarcinoma - drug therapy - genetics - mortality - pathology - surgery |
2 |
|
adenocarcinoma - drug therapy - genetics - pathology |
2 |
|
adenocarcinoma - epidemiology - genetics - pathology |
2 |
|
adenocarcinoma - genetics |
2 |
|
adolescent |
2 |
|
aged, 80 and over |
2 |
|
aneuploidy |
2 |
|
animal cell |
2 |
|
antibodies, monoclonal - diagnostic use |
2 |
|
antigens, viral - analysis |
2 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
2 |
|
article |
2 |
|
asian continental ancestry group - genetics |
2 |
|
autoradiography |
2 |
|
bacterial outer membrane proteins - analysis - genetics |
2 |
|
bacteriophage typing |
2 |
|
biopsy |
2 |
|
blu |
2 |
|
bronchiectasis - genetics |
2 |
|
campylobacter infections - epidemiology |
2 |
|
cancer cell culture |
2 |
|
cancer inhibition |
2 |
|
cancer stem cells |
2 |
|
carcinoma |
2 |
|
carcinoma, non-small-cell lung - epidemiology - genetics - pathology |
2 |
|
carcinoma, non-small-cell lung - ethnology - genetics - mortality |
2 |
|
carcinoma, non-small-cell lung - genetics |
2 |
|
carcinoma, small cell - genetics |
2 |
|
carcinoma, small cell - genetics - pathology |
2 |
|
carcinoma, squamous cell - epidemiology - genetics - pathology |
2 |
|
carcinoma, squamous cell - genetics - prevention & control |
2 |
|
cell growth processes - genetics |
2 |
|
chemotherapy |
2 |
|
chemotherapy, adjuvant |
2 |
|
child, preschool |
2 |
|
china - ethnology |
2 |
|
cholera - epidemiology - microbiology |
2 |
|
chromosome |
2 |
|
chromosome 3p |
2 |
|
chromosome 3q |
2 |
|
chromosome aberrations |
2 |
|
chromosome analysis |
2 |
|
chromosome inactivation |
2 |
|
chromosome loss |
2 |
|
chromosome structure |
2 |
|
chromosomes |
2 |
|
chromosomes, human, pair 16 |
2 |
|
chromosomes, human, pair 17 - genetics |
2 |
|
cis-regulatory elements |
2 |
|
colonic neoplasms - genetics - mortality - pathology |
2 |
|
colorectal neoplasms - drug therapy - genetics - mortality - pathology - surgery |
2 |
|
colorectal neoplasms - drug therapy - genetics - pathology |
2 |
|
colorectal neoplasms - genetics - mortality - pathology |
2 |
|
colorectal neoplasms - genetics - pathology |
2 |
|
controlled study |
2 |
|
cpg island |
2 |
|
cyclin-dependent kinase inhibitor p16 - genetics |
2 |
|
diarrhea - epidemiology - microbiology |
2 |
|
diarrhea - microbiology |
2 |
|
diarrhea, infantile - epidemiology - microbiology |
2 |
|
disease outbreaks |
2 |
|
disease-free survival |
2 |
|
dna - chemistry |
2 |
|
dna probes - chemistry |
2 |
|
dna repair |
2 |
|
dna replication |
2 |
|
dna, bacterial - genetics |
2 |
|
dna, neoplasm - analysis |
2 |
|
dna, neoplasm - genetics |
2 |
|
dna, viral - analysis |
2 |
|
enterotoxins - analysis - genetics |
2 |
|
enterotoxins - biosynthesis |
2 |
|
enterotoxins - genetics |
2 |
|
epigenesis, genetic |
2 |
|
escherichia coli - classification - genetics |
2 |
|
escherichia coli infections - epidemiology - microbiology |
2 |
|
esophageal neoplasms - genetics - prevention & control |
2 |
|
ethnic groups - genetics |
2 |
|
european continental ancestry group |
2 |
|
european continental ancestry group - genetics |
2 |
|
exon 2 |
2 |
|
exosomes |
2 |
|
expression quantitative trait loci (eqtl) |
2 |
|
extracellular matrix |
2 |
|
familial escc |
2 |
|
familial escc risk |
2 |
|
feces - microbiology |
2 |
|
fluorescence in situ hybridization |
2 |
|
fluorescent antibody technique |
2 |
|
follow-up studies |
2 |
|
functional profiling |
2 |
|
gene sequence |
2 |
|
genes, apc |
2 |
|
genes, bacterial |
2 |
|
genes, dcc |
2 |
|
genes, mcc |
2 |
|
genes, myc |
2 |
|
genes, myc - genetics |
2 |
|
genes, p16 - physiology |
2 |
|
genes, p53 - genetics |
2 |
|
genes, ras |
2 |
|
genes, tumor suppressor - genetics |
2 |
|
genetic alterations |
2 |
|
genetic polymorphism |
2 |
|
genome, viral |
2 |
|
genome-wide association study |
2 |
|
genome-wide association study (gwas) |
2 |
|
glutathione transferase - genetics |
2 |
|
gst |
2 |
|
hela cells |
2 |
|
herpesvirus 4, human |
2 |
|
herpesvirus 4, human - genetics |
2 |
|
heterozygote |
2 |
|
immunoblotting |
2 |
|
in situ |
2 |
|
in vitro study |
2 |
|
in vivo study |
2 |
|
incidence |
2 |
|
interferon regulatory factors - genetics |
2 |
|
interferon-gamma - physiology |
2 |
|
international agencies |
2 |
|
intron 2 |
2 |
|
irf8 |
2 |
|
isocitrate dehydrogenase - analysis - genetics |
2 |
|
isoenzymes - genetics |
2 |
|
itraq |
2 |
|
japan - ethnology |
2 |
|
ki-ras |
2 |
|
l-myc |
2 |
|
lipopolysaccharides - analysis |
2 |
|
loss of function mutation |
2 |
|
lung |
2 |
|
lung - cytology - pathology |
2 |
|
lung cancer |
2 |
|
lung neoplasms - epidemiology - genetics - pathology |
2 |
|
lung neoplasms - ethnology - genetics - mortality |
2 |
|
lung neoplasms - genetics |
2 |
|
microsatellite marker |
2 |
|
mouse |
2 |
|
mucous membrane - microbiology |
2 |
|
mus musculus |
2 |
|
mutation - genetics |
2 |
|
nasopharyngeal cell lines/xenograft (np460, hk1, c666, x666) |
2 |
|
nasopharyngeal neoplasms - immunology - microbiology |
2 |
|
neoplasm invasiveness - genetics - pathology |
2 |
|
ngs |
2 |
|
non-small cell lung carcinoma |
2 |
|
nonhuman |
2 |
|
nsclc |
2 |
|
organ specificity |
2 |
|
p16ink4a |
2 |
|
papovaviridae |
2 |
|
pathogenic variants |
2 |
|
polymerase chain reaction - methods |
2 |
|
polymorphisms |
2 |
|
prevalence |
2 |
|
promoter |
2 |
|
proteomic |
2 |
|
proto-oncogene proteins c-myc - genetics |
2 |
|
qualitative research |
2 |
|
quantitative study |
2 |
|
questionnaires |
2 |
|
rad50 |
2 |
|
ras oncogene |
2 |
|
rectal neoplasms - genetics - mortality - pathology |
2 |
|
repetitive sequences, nucleic acid |
2 |
|
restriction mapping |
2 |
|
retrospective studies |
2 |
|
rhob |
2 |
|
risk factors |
2 |
|
rna sequencing |
2 |
|
rotavirus infections - epidemiology |
2 |
|
salmonella infections - epidemiology |
2 |
|
scid mouse |
2 |
|
seasons |
2 |
|
sensitivity and specificity |
2 |
|
sequence deletion |
2 |
|
sequence homology, nucleic acid |
2 |
|
serotyping |
2 |
|
sex factors |
2 |
|
sigmoid neoplasms - genetics - mortality - pathology |
2 |
|
smoking - adverse effects |
2 |
|
species index: animalia |
2 |
|
species index: human herpesvirus 4 |
2 |
|
supernumerary chromosome |
2 |
|
transactivational ability |
2 |
|
transcriptome analysis |
2 |
|
transcriptome-wide association study (twas) |
2 |
|
tumor markers, biological |
2 |
|
tumor suppressor protein p53 - biosynthesis - genetics |
2 |
|
tumor suppressor protein p53 - genetics |
2 |
|
tumor suppressor protein p53 - metabolism |
2 |
|
tumorigenicity |
2 |
|
vesicle-associated membrane protein 8 (vamp8) |
2 |
|
vibrio cholerae - classification - genetics |
2 |
|
vibrio cholerae - genetics |
2 |
|
virulence - genetics |
2 |
|
wnt pathway |
2 |
|
wnt-c59 |
2 |
|
zinc hook domain |
2 |
|
acetyltransferases - genetics - physiology |
1 |
|
adaptor proteins, signal transducing - genetics |
1 |
|
adherens junctions |
1 |
|
aerodigestive tract cancers |
1 |
|
aflatoxin b1 |
1 |
|
aflatoxin b1 - toxicity |
1 |
|
agglutination tests - methods |
1 |
|
alcohol drinking - adverse effects |
1 |
|
antigens, bacterial - genetics |
1 |
|
antigens, viral |
1 |
|
antineoplastic agents - chemical synthesis - pharmacology |
1 |
|
antineoplastic agents - pharmacology |
1 |
|
antineoplastic agents - therapeutic use |
1 |
|
apoptosis - drug effects |
1 |
|
arxula |
1 |
|
arxula adeninivorans |
1 |
|
aryl hydrocarbon hydroxylases - genetics |
1 |
|
ascomycota |
1 |
|
asia - epidemiology - ethnology |
1 |
|
b-lymphocytes - microbiology |
1 |
|
bacterial toxins - analysis - immunology |
1 |
|
bacterial toxins - genetics |
1 |
|
biodegradable substances |
1 |
|
biodegradation, environmental |
1 |
|
biological assay |
1 |
|
biosensing techniques |
1 |
|
bod5 |
1 |
|
bronchi - microbiology |
1 |
|
calcium - metabolism |
1 |
|
california |
1 |
|
cancer -- research. |
1 |
|
capsid - genetics |
1 |
|
capsid proteins |
1 |
|
carbamates - chemistry |
1 |
|
carcinogens |
1 |
|
carcinoma - ethnology - microbiology |
1 |
|
carcinoma - microbiology |
1 |
|
carcinoma, bronchogenic - microbiology |
1 |
|
carcinoma, hepatocellular - genetics - metabolism - pathology |
1 |
|
carrier proteins - genetics |
1 |
|
carrier state - microbiology |
1 |
|
case-control studies |
1 |
|
caspase-12 |
1 |
|
caspases - metabolism |
1 |
|
cd90 |
1 |
|
cell division - drug effects |
1 |
|
cell proliferation - drug effects |
1 |
|
cell survival - drug effects |
1 |
|
cell-cycle arrest |
1 |
|
child |
1 |
|
cholera toxin - analysis - immunology |
1 |
|
chromosomes, human, pair 9 |
1 |
|
colorectal carcinoma |
1 |
|
colorectal carcinomas |
1 |
|
colorectal neoplasms - enzymology - genetics |
1 |
|
colorectal neoplasms - epidemiology - genetics |
1 |
|
colorectal neoplasms - genetics |
1 |
|
cpg dinucleotide |
1 |
|
cpg islands |
1 |
|
cross infection - microbiology |
1 |
|
cyclin-dependent kinase inhibitor p16 |
1 |
|
cyp2c9 |
1 |
|
cytokines |
1 |
|
deoxyribonuclease bamhi |
1 |
|
diarrhea, infantile - microbiology |
1 |
|
dinucleoside phosphates - metabolism |
1 |
|
dna restriction enzymes |
1 |
|
dna, complementary |
1 |
|
dna, neoplasm - analysis - genetics |
1 |
|
dna, neoplasm - isolation & purification |
1 |
|
dna, viral - genetics |
1 |
|
dna, viral - genetics - isolation & purification |
1 |
|
dna-cytosine methylases |
1 |
|
doxorubicin |
1 |
|
doxorubicin - metabolism - pharmacology |
1 |
|
drug resistance |
1 |
|
drug resistance, neoplasm - genetics |
1 |
|
electrophoresis, polyacrylamide gel |
1 |
|
emigration and immigration |
1 |
|
endemic diseases |
1 |
|
endoplasmic reticulum - physiology |
1 |
|
enterotoxins - analysis - immunology |
1 |
|
enterotoxins - biosynthesis - genetics |
1 |
|
environmental monitoring - methods |
1 |
|
enzyme activation - drug effects |
1 |
|
epstein-barr virus infections - complications - ethnology - genetics |
1 |
|
er-stress |
1 |
|
escherichia coli infections - microbiology |
1 |
|
escherichia coli proteins |
1 |
|
evaluation studies as topic |
1 |
|
fimbriae proteins |
1 |
|
flow cytometry |
1 |
|
fus2 |
1 |
|
g2 phase - drug effects |
1 |
|
gene amplification |
1 |
|
gene expression regulation |
1 |
|
gene frequency |
1 |
|
genes, p53 - drug effects |
1 |
|
genes, viral |
1 |
|
genetic association |
1 |
|
genetic variation |
1 |
|
hawaii |
1 |
|
health surveys |
1 |
|
herpesviridae infections - transmission |
1 |
|
herpesvirus 4, human - classification - genetics - isolation & purification |
1 |
|
herpesvirus 4, human - genetics - immunology - isolation & purification |
1 |
|
herpesvirus 4, human - genetics - isolation & purification |
1 |
|
histone modifications |
1 |
|
homozygote |
1 |
|
hot spot mutation |
1 |
|
hydrogels |
1 |
|
immunoassay - methods |
1 |
|
in situ nick-end labeling |
1 |
|
infant, newborn |
1 |
|
infectious mononucleosis - microbiology |
1 |
|
isoforms |
1 |
|
itgb1 |
1 |
|
japan |
1 |
|
jnk mitogen-activated protein kinases - metabolism |
1 |
|
lim domain proteins - genetics |
1 |
|
linear models |
1 |
|
liver cancer |
1 |
|
liver neoplasms - genetics - metabolism - pathology |
1 |
|
local tumor |
1 |
|
longitudinal studies |
1 |
|
loss of heterozygosity - genetics |
1 |
|
lung neoplasms - microbiology |
1 |
|
lymphocyte activation |
1 |
|
lymphocytes - microbiology |
1 |
|
mapk |
1 |
|
medical records |
1 |
|
metalloporphyrins - chemical synthesis - pharmacology |
1 |
|
metalloporphyrins - therapeutic use |
1 |
|
mgst1 |
1 |
|
microbial sensor |
1 |
|
microsomes - enzymology |
1 |
|
microspheres |
1 |
|
mir-134 |
1 |
|
mitochondria - physiology |
1 |
|
mitochondrial membrane potential |
1 |
|
mutagens |
1 |
|
nasopharyngeal neoplasms - complications - ethnology - genetics |
1 |
|
nasopharyngeal neoplasms - drug therapy - metabolism |
1 |
|
nasopharyngeal neoplasms - drug therapy - pathology |
1 |
|
nasopharyngeal neoplasms - ethnology - genetics |
1 |
|
nasopharyngeal neoplasms - ethnology - microbiology |
1 |
|
nasopharyngeal neoplasms - ethnology - virology |
1 |
|
nasopharyngeal neoplasms - microbiology |
1 |
|
nasopharyngeal neoplasms - microbiology - pathology |
1 |
|
nasopharyngeal neoplasms - pathology |
1 |
|
nasopharynx - microbiology |
1 |
|
neoplasm metastasis - genetics |
1 |
|
p-glycoprotein |
1 |
|
p-glycoprotein - metabolism |
1 |
|
p16 gene |
1 |
|
p38 |
1 |
|
p38 mitogen-activated protein kinases - metabolism |
1 |
|
p53 mutation |
1 |
|
paclitaxel - metabolism - pharmacology |
1 |
|
pcr-sscp |
1 |
|
pd169316 |
1 |
|
pdgf-rβ |
1 |
|
perylene - analogs & derivatives - pharmacology - therapeutic use |
1 |
|
pharynx - microbiology |
1 |
|
photochemotherapy |
1 |
|
photodynamic therapy |
1 |
|
photosensitizing agents - chemical synthesis - pharmacology |
1 |
|
photosensitizing agents - therapeutic use |
1 |
|
plasmids - drug effects - genetics |
1 |
|
polyesters - chemistry |
1 |
|
polymorphism, genetic - genetics |
1 |
|
polymorphism, single nucleotide - genetics |
1 |
|
protein structure, tertiary |
1 |
|
ptpn22 |
1 |
|
pyropheophorbide-a methyl ester |
1 |
|
retroviridae infections - microbiology |
1 |
|
rna, small interfering |
1 |
|
rna, viral - genetics |
1 |
|
rotavirus - classification - genetics - isolation & purification |
1 |
|
rotavirus infections - epidemiology - microbiology |
1 |
|
saccharomyces cerevisiae - drug effects - genetics |
1 |
|
seawater |
1 |
|
seawater measurements |
1 |
|
sensorbod |
1 |
|
sequence analysis, dna |
1 |
|
single nucleotide polymorphism |
1 |
|
snp |
1 |
|
sodium chloride - pharmacology |
1 |
|
src |
1 |
|
subcellular fractions |
1 |
|
superoxide dismutase - physiology |
1 |
|
templates, genetic |
1 |
|
thailand |
1 |
|
tumor suppressor protein p53 - genetics - metabolism |
1 |
|
tumor virus infections |
1 |
|
up-regulation |
1 |
|
virulence |
1 |
|
waste disposal, fluid |
1 |
|
wnt |
1 |
|
yeast assay |
1 |
|
yeast p53 functional assay |
1 |
|
yeasts - genetics |
1 |
|
yeasts - metabolism |
1 |
